Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05522504

Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
Ai Peng · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate whether immune cells and their subtypes in peripheral blood affects the asymptomatic hyperuricemia, gout flare, intercritical gout and advanced gout.

Detailed description

A number of studies have reported that innate immunity cells (such as blood monocytes and neutrophils) play a crucial role in the initiation and amplification of gout flare resulted from MSU deposition in the joint or tissue, leading to release NLRP3 inflammasome-mediated production of bioactive IL-1β. Further investigation demonstrated the role of blood neutrophils might contribute to the resolution of gout flare by forming aggregated neutrophil extracellular traps. Recently, a few in vitro experiments have indicated that adaptive immunity may be involved in mechanisms of gout. However, a global understanding of blood immune responses underlying gout is still unclear. Thus, we want to investigate the relationship between immune cells and their subtypes in peripheral blood and the gout.

Conditions

Timeline

Start date
2022-09-15
Primary completion
2023-02-15
Completion
2025-02-01
First posted
2022-08-31
Last updated
2024-05-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05522504. Inclusion in this directory is not an endorsement.